New York, NY · Founded 2016 · Privately Held (backing)
Developer of an intra-operative nerve visualization technology intended to reduce the risk of nerve damage. Illuminare Biotechnologies is based in New York, NY and was founded in 2016. Its last reported valuation was $11.4 million in Aug 2017. It has raised $7.1 million across 1 recorded round; the latest was a $3.6 million seed round in May 2026.
Last reported valuation
$11.4M
Oct 2026
Priced at
—
Total raised
$7.1M
Last round
Seed Round
May 2026
Cap table — not yet on record
Illuminare Biotechnologies's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Where does Illuminare Biotechnologies's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Illuminare Biotechnologies's 1 recorded funding rounds.
